Global Pediatric Medicines Market 2017-2021

小児用薬剤の世界市場

◆タイトル:Global Pediatric Medicines Market 2017-2021
◆商品コード:IRTNTR13978
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年8月2日
◆ページ数:91
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、小児用薬剤の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、小児用薬剤の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は小児用薬剤の世界市場が2017-2021年期間中に年平均4.97%成長すると予測しています。当レポート上に記載されている主な企業は• GSK• Novartis• Pfizer• Sanofi等です。

About Pediatric MedicinesThe pediatric drug market plays a pivotal role in the pharmaceutical industry. There are several vendors, who provide healthcare services and products for pediatric population. The pediatric medicines market is one of the important segments in the pharmaceutical industry. Infants are prone to infections owing to their under-developed immune system. The presence of a large pediatric population, especially in APAC combined with the population being more prone to infections and illness will increase the demand for pediatric medicines.
The pediatric medicines market is one of the emerging markets in the pharmaceutical sphere with huge unmet needs and requires support for better innovation and higher R&D investments.

Technavio’s analysts forecast the global pediatric medicines market to grow at a CAGR of 4.97% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global pediatric medicines market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Pediatric Medicines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• GSK
• Novartis
• Pfizer
• Sanofi

[Other prominent vendors]
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai Pharmaceuticals
• Eli Lilly
• F. Hoffman-La Roche
• Glenmark
• Helsinn Healthcare
• Heron Therapeutics
• Ipca Laboratories
• Lupin Pharmaceuticals
• Merck Sharp & Dohme
• RedHill
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical

[Market driver]
• High pediatric population
• For a full, detailed list, view our report

[Market challenge]
• Usage of off-label drugs
• For a full, detailed list, view our report

[Market trend]
• Inorganic growth strategies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market overview
• Five forces analysis

PART 06: Pipeline analysis
• Phase I molecules
• Phase II molecules
• Phase III molecules

PART 07: Market segmentation by Route of drug administration
• Enteral RoA
• Parenteral RoA
• Topical RoA

PART 08: Market segmentation by disease type
• Respiratory diseases
• Infectious diseases
• Gastrointestinal diseases
• CNS diseases
• Oncological diseases
• CVDs
• Others

PART 09: Geographical segmentation
• Pediatric medicines market in Americas
• Pediatric medicines market in EMEA
• Pediatric medicines market in APAC

PART 10: Drivers and challenges
• Market drivers
• Market challenges
• Oral soluble films

PART 11: Market trends
• Inorganic growth strategies
• Government initiatives

PART 12: Vendor landscape
• Competitive scenario

PART 13: Key vendor analysis
• GSK
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Factors influencing the global pediatric medicines market
Exhibit 02: Key focused therapeutic areas in global pediatric medicines market
Exhibit 03: Major acute pediatric diseases
Exhibit 04: Major chronic pediatric diseases
Exhibit 05: Global pediatric medicines market: Major growth drivers
Exhibit 06: Global pediatric medicines market 2016-2021 ($ billions)
Exhibit 07: Opportunity analysis in global pediatric medicines market
Exhibit 08: Five forces analysis
Exhibit 09: Phase I: Key molecules by vendors
Exhibit 10: Phase I: Key molecules landscape
Exhibit 11: Phase II: Key molecules by vendors
Exhibit 12: Phase II: Key molecules landscape
Exhibit 13: Phase III: Key molecules by vendors
Exhibit 14: Phase III: Key molecules landscape
Exhibit 15: Market segmentation by RoA 2016
Exhibit 16: Characteristics of enteral RoA
Exhibit 17: Global pediatric enteral medicines market 2016-2021 ($ billion)
Exhibit 18: Advantages of liquid dosage form over other enteral routes
Exhibit 19: Global pediatric parenteral medicines market 2016-2021 ($ billion)
Exhibit 20: Various routes of parenteral route administration
Exhibit 21: Various formulations of topical administration
Exhibit 22: Global pediatric topical medicines market 2016-2021 ($ billion)
Exhibit 23: Advantages of topical route of drug administration
Exhibit 24: Global pediatric medicines market segmentation by disease type
Exhibit 25: Various types of respiratory diseases in pediatric population
Exhibit 26: Various types of infectious diseases in pediatric population
Exhibit 27: Various types of gastrointestinal diseases in pediatric population
Exhibit 28: Various types of CNS disorders in Pediatric patients
Exhibit 29: Major oncological disorders seen in pediatric patients
Exhibit 30: Various types of CVDs in pediatric patient
Exhibit 31: Segmentation of global pediatric medicines market by geography 2016 and 2021
Exhibit 32: Global pediatric medicines market by geography 2016-2021 ($ billions)
Exhibit 33: Market scenario in Americas
Exhibit 34: Pediatric medicines market in Americas 2016-2021 ($ billions)
Exhibit 35: Market scenario in EMEA
Exhibit 36: Pediatric medicines market in EMEA 2016-2021 ($ billion)
Exhibit 37: Market Scenario in APAC
Exhibit 38: Pediatric medicines market in APAC 2016-2021 ($ billion)
Exhibit 39: Pediatric population in US 1980-2050
Exhibit 40: Few phase III molecules for pediatric application
Exhibit 41: Few commonly used off-label drugs for pediatric patients
Exhibit 42: Various challenges in pediatric clinical trials
Exhibit 43: Inorganic growth strategies
Exhibit 44: Various government initiatives
Exhibit 45: Competitive structure analysis of global pediatric medicines market 2016
Exhibit 46: Market penetration of various pediatric medicines manufacturers worldwide 2016
Exhibit 47: Strategic success factors of companies in global pediatric medicines market
Exhibit 48: GSK: Key highlights
Exhibit 49: GSK: Strength assessment
Exhibit 50: GSK: Strategy assessment
Exhibit 51: GSK: Opportunity assessment
Exhibit 52: Novartis: Key highlights
Exhibit 53: Novartis: Strength assessment
Exhibit 54: Novartis: Strategy assessment
Exhibit 55: Novartis: Opportunity assessment
Exhibit 56: Pfizer: Key highlights
Exhibit 57: Pfizer: Strength assessment
Exhibit 58: Pfizer: Strategy assessment
Exhibit 59: Pfizer: Opportunity assessment
Exhibit 60: Sanofi: Key highlights
Exhibit 61: Sanofi: Strength assessment
Exhibit 62: Sanofi: Strategy assessment
Exhibit 63: Sanofi: Opportunity assessment



【掲載企業】

GSK, Novartis, Pfizer, and Sanofi

Other Prominent Vendors in the market are: Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories, Lupin Pharmaceuticals, Merck Sharp & Dohme, RedHill, Sun Pharmaceutical Industries, and Takeda Pharmaceutical.


【資料のキーワード】

小児用薬剤

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[小児用薬剤の世界市場] (Global Pediatric Medicines Market 2017-2021 / IRTNTR13978)販売に関する免責事項
[小児用薬剤の世界市場] (Global Pediatric Medicines Market 2017-2021 / IRTNTR13978)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆